This study is the first to clarify the protection and mechanisms of irisin in vascular remodeling by regulating ER function, potentially providing new biomarkers and pharmacological targets for chronic vascular remodeling in hypertension. The gene discussed is FNDC5; the disease is hypertensive disorder.